| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |